Bank of New York Mellon »

Aktis Oncology shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Aktis Oncology shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Aktis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Aktis Oncology held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aktis Oncology by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2026-03-31 $768k 43k 17.89

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc-cl A Cap (GOOGL)
Broadcom (AVGO)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Inc-cl C Cap (GOOG)
Meta Platforms Inc-class A Cl A (META)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Johnson & Johnson (JNJ)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Eli Lilly & Co. (LLY)

View all positions for Bank of New York Mellon

Top funds holding Aktis Oncology

MPM Oncology Impact Management
EcoR1 Capital
Blue Owl Capital Holdings
Wellington Management Company
BlackRock
Rtw Investments
RA Capital Management
Henderson Group
Baker Bros. Advisors
Octagon Capital Advisors
Merck & Co
Vanguard Capital Management
Eventide Asset Management
Geode Capital Management
Avidity Partners Management

View all funds holding Aktis Oncology